1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Weber, T. Schaffhausen, B. Liu, Y. Guenther, U.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C9 H12 N O6 P 261.168 n O-PHOSPHOTYROSINE PHOSPHONOTYROSINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 39 15860 15869 10.1021/bi001474d 11123912 NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site. 2000 10.2210/pdb1fu5/pdb pdb_00001fu5 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 12870.384 PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY ALPHA SUBUNIT RESIDUES 321 TO 431 OF P85, N-SH2 (SRC HOMOLOGY 2) DOMAIN 1 man polymer 2063.089 DOUBLY PHOSPHORYLATED MIDDLE T ANTIGEN RESIDUES 312 TO 326 OF MT ANTIGEN, Y315 AND Y322 PHOSPHORYLATED 1 syn polymer PI3-KINASE P85-ALPHA SUBUNIT, PTDINS-3-KINASE P85-ALPHA, PI3K MT PEPTIDE no no GMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKSIKIFHRDGKYGFSDPLTFNS VVELINHYRNESLAQYNPKLDVKLLYPVSKY GMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKSIKIFHRDGKYGFSDPLTFNS VVELINHYRNESLAQYNPKLDVKLLYPVSKY A polypeptide(L) no yes EEE(PTR)MPMEDL(PTR)LDIL EEEYMPMEDLYLDIL B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Norway rat Rattus Escherichia sample 10116 Rattus norvegicus 562 Escherichia coli database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2001-02-21 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_ref_seq_dif.details 1FU6 is NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3-KINASE RCSB Y RCSB 2000-09-14 REL MT peptide was synthesized by the Tufts Protein Chemistry Facility sample NOESY assignments were obtained by a semi-automatic procedure employing a program from Pristovsek [Pristovsek, P. & Kidric, J. (1997) Biopol. 42, 671-679)]. Initial calculations included only intramolecular constraints. The observed NOEs derived from 13C{F1}-filtered 2D-NOESY spectra were incorporated into the structure calculation when the protein fold was already correct. structures with favorable non-bond energy 110 1 2D NOESY 3D_13C-separated_NOESY 3D_15N-separated_NOESY 13C{F1}-filtered 2D-NOESY 0.1mM 6.8 1 bar 305 K The structure with the lowest energy is presented The structures were energy minimized with MSI DISCOVER. 1 lowest energy 0.15mM N-SH2 15N, 13C; MT peptide; 0.1mM KCl; 95% H2O, 5% D2O 100% H2O Ulrich Guenther, Christian Ludwig and Heinz Rueterjans processing NMRLAB M. Kjaer data analysis Pronto P. Pristovsek data analysis nmr2st P. Guentert structure solution DYANA MSI refinement Discover 500 Bruker DMX 600 Bruker DMX GLY 1 n 1 GLY 1 A MET 2 n 2 MET 2 A ASN 3 n 3 ASN 3 A ASN 4 n 4 ASN 4 A ASN 5 n 5 ASN 5 A MET 6 n 6 MET 6 A SER 7 n 7 SER 7 A LEU 8 n 8 LEU 8 A GLN 9 n 9 GLN 9 A ASP 10 n 10 ASP 10 A ALA 11 n 11 ALA 11 A GLU 12 n 12 GLU 12 A TRP 13 n 13 TRP 13 A TYR 14 n 14 TYR 14 A TRP 15 n 15 TRP 15 A GLY 16 n 16 GLY 16 A ASP 17 n 17 ASP 17 A ILE 18 n 18 ILE 18 A SER 19 n 19 SER 19 A ARG 20 n 20 ARG 20 A GLU 21 n 21 GLU 21 A GLU 22 n 22 GLU 22 A VAL 23 n 23 VAL 23 A ASN 24 n 24 ASN 24 A GLU 25 n 25 GLU 25 A LYS 26 n 26 LYS 26 A LEU 27 n 27 LEU 27 A ARG 28 n 28 ARG 28 A ASP 29 n 29 ASP 29 A THR 30 n 30 THR 30 A ALA 31 n 31 ALA 31 A ASP 32 n 32 ASP 32 A GLY 33 n 33 GLY 33 A THR 34 n 34 THR 34 A PHE 35 n 35 PHE 35 A LEU 36 n 36 LEU 36 A VAL 37 n 37 VAL 37 A ARG 38 n 38 ARG 38 A ASP 39 n 39 ASP 39 A ALA 40 n 40 ALA 40 A SER 41 n 41 SER 41 A THR 42 n 42 THR 42 A LYS 43 n 43 LYS 43 A MET 44 n 44 MET 44 A HIS 45 n 45 HIS 45 A GLY 46 n 46 GLY 46 A ASP 47 n 47 ASP 47 A TYR 48 n 48 TYR 48 A THR 49 n 49 THR 49 A LEU 50 n 50 LEU 50 A THR 51 n 51 THR 51 A LEU 52 n 52 LEU 52 A ARG 53 n 53 ARG 53 A LYS 54 n 54 LYS 54 A GLY 55 n 55 GLY 55 A GLY 56 n 56 GLY 56 A ASN 57 n 57 ASN 57 A ASN 58 n 58 ASN 58 A LYS 59 n 59 LYS 59 A SER 60 n 60 SER 60 A ILE 61 n 61 ILE 61 A LYS 62 n 62 LYS 62 A ILE 63 n 63 ILE 63 A PHE 64 n 64 PHE 64 A HIS 65 n 65 HIS 65 A ARG 66 n 66 ARG 66 A ASP 67 n 67 ASP 67 A GLY 68 n 68 GLY 68 A LYS 69 n 69 LYS 69 A TYR 70 n 70 TYR 70 A GLY 71 n 71 GLY 71 A PHE 72 n 72 PHE 72 A SER 73 n 73 SER 73 A ASP 74 n 74 ASP 74 A PRO 75 n 75 PRO 75 A LEU 76 n 76 LEU 76 A THR 77 n 77 THR 77 A PHE 78 n 78 PHE 78 A ASN 79 n 79 ASN 79 A SER 80 n 80 SER 80 A VAL 81 n 81 VAL 81 A VAL 82 n 82 VAL 82 A GLU 83 n 83 GLU 83 A LEU 84 n 84 LEU 84 A ILE 85 n 85 ILE 85 A ASN 86 n 86 ASN 86 A HIS 87 n 87 HIS 87 A TYR 88 n 88 TYR 88 A ARG 89 n 89 ARG 89 A ASN 90 n 90 ASN 90 A GLU 91 n 91 GLU 91 A SER 92 n 92 SER 92 A LEU 93 n 93 LEU 93 A ALA 94 n 94 ALA 94 A GLN 95 n 95 GLN 95 A TYR 96 n 96 TYR 96 A ASN 97 n 97 ASN 97 A PRO 98 n 98 PRO 98 A LYS 99 n 99 LYS 99 A LEU 100 n 100 LEU 100 A ASP 101 n 101 ASP 101 A VAL 102 n 102 VAL 102 A LYS 103 n 103 LYS 103 A LEU 104 n 104 LEU 104 A LEU 105 n 105 LEU 105 A TYR 106 n 106 TYR 106 A PRO 107 n 107 PRO 107 A VAL 108 n 108 VAL 108 A SER 109 n 109 SER 109 A LYS 110 n 110 LYS 110 A TYR 111 n 111 TYR 111 A GLU 1 n 1 GLU 1 B GLU 2 n 2 GLU 2 B GLU 3 n 3 GLU 3 B PTR 4 n 4 PTR 4 B MET 5 n 5 MET 5 B PRO 6 n 6 PRO 6 B MET 7 n 7 MET 7 B GLU 8 n 8 GLU 8 B ASP 9 n 9 ASP 9 B LEU 10 n 10 LEU 10 B PTR 11 n 11 PTR 11 B LEU 12 n 12 LEU 12 B ASP 13 n 13 ASP 13 B ILE 14 n 14 ILE 14 B LEU 15 n 15 LEU 15 B author_defined_assembly 2 dimeric B PTR 4 O-PHOSPHOTYROSINE B PTR 4 TYR B PTR 11 O-PHOSPHOTYROSINE B PTR 11 TYR 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B HD22 HXT LEU LEU 12 15 1.06 1 A A HZ1 HZ3 LYS LYS 26 110 1.24 1 A A HB3 HZ3 ASP LYS 67 69 1.26 1 A A O H LEU THR 36 51 1.55 1 A A O H LEU GLN 93 95 1.56 1 A A H O ASP ILE 47 63 1.57 1 A A O H GLU ASN 21 24 1.58 1 B B C OXT LEU LEU 15 15 0.151 0.019 1.229 1.380 N 1 A ASN 3 58.86 87.69 1 A MET 6 -179.89 139.89 1 A SER 7 62.20 154.39 1 A GLN 9 34.23 40.07 1 A ASP 10 -159.73 31.83 1 A GLU 12 65.24 -73.92 1 A TYR 14 -87.84 34.40 1 A ASP 17 52.00 108.25 1 A SER 19 76.53 103.52 1 A ARG 20 -30.12 -70.27 1 A ASP 29 175.70 39.58 1 A THR 30 -55.68 -77.66 1 A THR 34 -82.27 45.72 1 A PHE 35 -42.98 163.63 1 A LEU 36 177.95 155.86 1 A ARG 38 -137.31 -44.29 1 A ASP 39 57.01 147.06 1 A ALA 40 -177.42 -138.79 1 A THR 42 -54.68 89.14 1 A HIS 45 -101.53 71.35 1 A TYR 48 -158.95 28.77 1 A THR 49 47.82 -176.16 1 A LEU 50 178.90 145.00 1 A ASN 58 60.90 119.69 1 A SER 60 168.91 -47.41 1 A ILE 61 57.27 141.32 1 A LYS 62 174.57 143.71 1 A ARG 66 -138.93 -85.01 1 A ASP 67 -100.04 61.81 1 A TYR 70 -53.87 -165.98 1 A PHE 72 -36.50 -31.83 1 A ASP 74 61.83 86.70 1 A THR 77 152.61 44.96 1 A VAL 81 -90.69 38.51 1 A ASN 90 151.18 116.95 1 A GLU 91 154.99 -18.51 1 A SER 92 89.48 160.90 1 A ALA 94 -65.37 64.20 1 A GLN 95 -66.53 -84.37 1 A ASN 97 -178.70 148.35 1 A PRO 98 -75.00 48.19 1 A LEU 100 -125.30 -76.80 1 A ASP 101 30.35 66.06 1 A LYS 103 78.26 164.55 1 A LEU 104 -160.29 27.24 1 A LYS 110 46.20 93.25 1 B GLU 3 -77.45 -121.99 1 B MET 7 169.34 152.39 1 B GLU 8 174.66 -99.29 1 B ASP 9 73.44 126.14 1 B LEU 10 -36.75 137.47 1 B ASP 13 43.22 -165.34 NMR STRUCTURE OF THE N-SH2 DOMAIN OF THE P85 SUBUNIT OF PI3-KINASE COMPLEXED TO A DOUBLY PHOSPHORYLATED PEPTIDE DERIVED FROM POLYOMAVIRUS MIDDLE T ANTIGEN 1 N N 2 N N A SER 19 A SER 19 HELX_P A LEU 27 A LEU 27 1 1 9 A VAL 82 A VAL 82 HELX_P A TYR 88 A TYR 88 1 2 7 covale 1.325 both B GLU 3 B C GLU 3 1_555 B PTR 4 B N PTR 4 1_555 covale 1.324 both B PTR 4 B C PTR 4 1_555 B MET 5 B N MET 5 1_555 covale 1.325 both B LEU 10 B C LEU 10 1_555 B PTR 11 B N PTR 11 1_555 covale 1.325 both B PTR 11 B C PTR 11 1_555 B LEU 12 B N LEU 12 1_555 PEPTIDE BINDING PROTEIN protein-peptide complex, PEPTIDE BINDING PROTEIN P85A_RAT UNP 1 321 Q63787 GMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFNS VVELINHYRNESLAQYNPKLDVKLLYPVSKY TAMI_POVM3 UNP 2 331 P03076 EEEYMPMEDLYLDIL 321 431 1FU5 1 111 Q63787 A 1 1 111 331 345 1FU5 1 15 P03076 B 2 1 15 1 LEU conflict SER 60 1FU5 A Q63787 UNP 380 60 2 TYR modified residue PTR 4 1FU5 B P03076 UNP 334 4 2 TYR modified residue PTR 11 1FU5 B P03076 UNP 341 11 1 P 1